Federation des caisses Desjardins du Quebec’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.43M | Buy |
81,627
+29
| +0% | +$924 | 0.01% | 627 |
|
|
2026
Q1 | $2.16M | Buy |
81,598
+721
| +0.9% | +$21.1K | 0.01% | 718 |
|
|
2025
Q4 | $2.34M | Buy |
80,877
+2,510
| +3% | +$75.3K | 0.01% | 676 |
|
|
2025
Q3 | $2.18M | Buy |
78,367
+2,906
| +4% | +$73.4K | 0.01% | 688 |
|
|
2025
Q2 | $1.84M | Buy |
75,461
+1,161
| +2% | +$25.4K | 0.01% | 680 |
|
|
2025
Q1 | $1.54M | Buy |
74,300
+10,651
| +17% | +$268K | 0.01% | 697 |
|
|
2024
Q4 | $1.5M | Buy |
63,649
+61,147
| +2,444% | +$1.5M | 0.01% | 684 |
|
|
2024
Q3 | $64.1K | Sell |
2,502
-94
| -4% | -$2.39K | ﹤0.01% | 1362 |
|
|
2024
Q2 | $61K | Sell |
2,596
-208
| -7% | -$5.25K | ﹤0.01% | 1349 |
|
|
2024
Q1 | $80.6K | Sell |
2,804
-215
| -7% | -$6.46K | ﹤0.01% | 1291 |
|
|
2023
Q4 | $99.1K | Hold |
3,019
| – | – | ﹤0.01% | 1127 |
|
|
2023
Q3 | $84.1K | Sell |
3,019
-145
| -5% | -$4.74K | ﹤0.01% | 1179 |
|
|
2023
Q2 | $108K | Sell |
3,164
-57
| -2% | -$1.79K | ﹤0.01% | 1133 |
|
|
2023
Q1 | $96.9K | Sell |
3,221
-178
| -5% | -$5.51K | ﹤0.01% | 1159 |
|
|
2022
Q4 | $96K | Sell |
3,399
-540
| -14% | -$17.1K | ﹤0.01% | 1283 |
|
|
2022
Q3 | $129K | Buy |
3,939
+90
| +2% | +$3.3K | ﹤0.01% | 1234 |
|
|
2022
Q2 | $121K | Hold |
3,849
| – | – | ﹤0.01% | 1278 |
|
|
2022
Q1 | $177K | Buy |
3,849
+606
| +19% | +$28.9K | ﹤0.01% | 1179 |
|
|
2021
Q4 | $199K | Sell |
3,243
-2,002
| -38% | -$138K | ﹤0.01% | 1160 |
|
|
2021
Q3 | $392K | Sell |
5,245
-2,512
| -32% | -$211K | ﹤0.01% | 943 |
|
|
2021
Q2 | $718K | Buy |
7,757
+2,400
| +45% | +$204K | 0.01% | 791 |
|
|
2021
Q1 | $475K | Buy |
5,357
+4,239
| +379% | +$420K | 0.01% | 849 |
|
|
2020
Q4 | $104K | Buy |
+1,118
| New | +$89.1K | ﹤0.01% | 1268 |
|
|
2020
Q3 | – | Sell |
-500
| Closed | -$26.1K | – | 2164 |
|
|
2020
Q2 | $26.1K | Hold |
500
| – | – | ﹤0.01% | 1381 |
|
|
2020
Q1 | $15.6K | Hold |
500
| – | – | ﹤0.01% | 1556 |
|
|
2019
Q4 | $16.8K | Hold |
500
| – | – | ﹤0.01% | 1765 |
|
|
2019
Q3 | $14.8K | Hold |
500
| – | – | ﹤0.01% | 1735 |
|
|
2019
Q2 | $17.2K | Hold |
500
| – | – | ﹤0.01% | 1718 |
|
|
2019
Q1 | $16.4K | Hold |
500
| – | – | ﹤0.01% | 1557 |
|
|
2018
Q4 | $12K | Hold |
500
| – | – | ﹤0.01% | 1582 |
|
|
2018
Q3 | $16.7K | Hold |
500
| – | – | ﹤0.01% | 1601 |
|
|
2018
Q2 | $14.5K | Sell |
500
-550
| -52% | -$15.3K | ﹤0.01% | 1654 |
|
|
2018
Q1 | $27K | Hold |
1,050
| – | – | ﹤0.01% | 1493 |
|
|
2017
Q4 | $25.7K | Buy |
+1,050
| New | +$26.6K | ﹤0.01% | 1515 |
|
Other funds holding ARKG
JFG
Federation des caisses Desjardins du Quebec's ARKG Position: Q2 2026 in Review
Federation des caisses Desjardins du Quebec increased its ARK Genomic Revolution ETF (ARKG) stake by 0.04% in Q2 2026, buying an estimated $924 and bringing the position to 81,627 shares worth $3.43M. The position accounts for 0.01% of the portfolio, ranked #627.
Federation des caisses Desjardins du Quebec first reported a position in ARKG in Q4 2017 and has held it in 34 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Federation des caisses Desjardins du Quebec held 81,627 shares of ARK Genomic Revolution ETF worth $3.43M as of Q2 2026.
- Federation des caisses Desjardins du Quebec bought 29 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $924.
- ARK Genomic Revolution ETF made up 0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #627 holding.
- Federation des caisses Desjardins du Quebec first reported a position in ARK Genomic Revolution ETF in Q4 2017 and has held it in 34 quarters since.
- 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.